---
title: "Viking Therapeutics (VKTX) Receives a Buy from Jefferies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294386403.md"
description: "Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX) with a $101 price target. Song, a 3-star analyst covering healthcare stocks, holds a 40.98% success rate. The broader analyst consensus for VKTX is a Strong Buy, with an average price target of $94.17."
datetime: "2026-07-30T14:45:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294386403.md)
  - [en](https://longbridge.com/en/news/294386403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294386403.md)
generator: "portal-rs"
---

# Viking Therapeutics (VKTX) Receives a Buy from Jefferies

In a report released today, Roger Song from Jefferies maintained a Buy rating on Viking Therapeutics, with a price target of $101.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Song is a 3-star analyst with an average return of 2.0% and a 40.98% success rate. Song covers the Healthcare sector, focusing on stocks such as Nurix Therapeutics, Kailera Therapeutics, Inc., and United Therapeutics.

Currently, the analyst consensus on Viking Therapeutics is a Strong Buy with an average price target of $94.17.

### Related Stocks

- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [NRIX.US](https://longbridge.com/en/quote/NRIX.US.md)
- [KLRA.US](https://longbridge.com/en/quote/KLRA.US.md)
- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [Viking Therapeutics to present at Morgan Stanley Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297823727.md)
- [Stifel Nicolaus Keeps Their Buy Rating on Viking Therapeutics (VKTX)](https://longbridge.com/en/news/294373097.md)
- [Egetis Therapeutics CEO to join fireside chats at Cantor, Morgan Stanley healthcare conferences](https://longbridge.com/en/news/297867901.md)
- [Alliance Global Partners Sticks to Their Buy Rating for Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/297544479.md)
- [Akebia Therapeutics holds investor meetings at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297649009.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**